Beam Therapeutics Inc.
BEAM
Cena:
$ 28.64
+0.97 (3.51%)
Valuace
100
Růst
75
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| FMR LLC | 12.5 mil | 12.59% | 0.00% | 0.02% | 2020-03-31 |
| ARK INVESTMENT MANAGEMENT LLC | 12.1 mil | 12.27% | -0.05% | 2.25% | 2020-12-31 |
| FARALLON CAPITAL MANAGEMENT LLC | 10.1 mil | 10.25% | 0.11% | 1.38% | 2021-03-31 |
| BLACKROCK INC. | 7.6 mil | 9.34% | 0.00% | 0.00% | 2020-03-31 |
| BLACKROCK FUNDING, INC. /DE | 7.7 mil | 9.31% | 0.00% | 0.00% | 2024-09-30 |
| VANGUARD GROUP INC | 9.2 mil | 8.96% | 0.00% | 0.00% | 2020-03-31 |
| BLACKROCK, INC. | 8.5 mil | 8.58% | 0.00% | 0.00% | 2024-09-30 |
| STATE STREET CORP | 5.7 mil | 5.76% | 0.00% | 0.00% | 2020-03-31 |
| ARCH VENTURE MANAGEMENT, LLC | 4.5 mil | 4.59% | -3.33% | 15.98% | 2024-06-30 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.8 mil | 3.87% | -0.12% | 1.29% | 2020-12-31 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 3.8 mil | 3.87% | -0.01% | 0.06% | 2020-12-31 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.7 mil | 3.72% | 1.09% | 5.41% | 2024-09-30 |
| BELLEVUE GROUP AG | 2.9 mil | 2.83% | 0.37% | 1.46% | 2020-12-31 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 2.1 mil | 2.75% | 9.32% | 9.32% | 2024-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.7 mil | 2.74% | 0.00% | 0.01% | 2020-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4 mil | 2.45% | 0.00% | 0.00% | 2020-03-31 |
| MWG MANAGEMENT LTD. | 2.3 mil | 2.22% | -6.64% | 67.66% | 2020-12-31 |
| DIMENSIONAL FUND ADVISORS LP | 2.2 mil | 2.18% | 0.00% | 0.01% | 2021-03-31 |
| TEMASEK HOLDINGS (PRIVATE) LTD | 1.8 mil | 2.06% | -0.03% | 0.14% | 2020-03-31 |
| JANUS HENDERSON GROUP PLC | 1.8 mil | 1.99% | 0.02% | 0.02% | 2022-03-31 |
| FIRST TRUST ADVISORS LP | 1.5 mil | 1.81% | 0.04% | 0.04% | 2024-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 1.7 mil | 1.67% | 0.00% | 0.01% | 2020-12-31 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.4 mil | 1.46% | 2.03% | 2.03% | 2026-03-31 |
| CASDIN CAPITAL, LLC | 1.4 mil | 1.36% | -0.32% | 2.44% | 2020-12-31 |
| REDMILE GROUP, LLC | 1.2 mil | 1.25% | -0.67% | 1.95% | 2020-03-31 |
| TWO SIGMA INVESTMENTS, LP | 1.2 mil | 1.22% | -0.02% | 0.02% | 2024-03-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.1 mil | 1.10% | 0.02% | 0.03% | 2025-06-30 |
| DEUTSCHE BANK AG\ | 861.99 tis | 1.06% | 0.01% | 0.01% | 2020-03-31 |
| GOLDMAN SACHS GROUP INC | 1.0 mil | 1.02% | 0.00% | 0.00% | 2020-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 877.81 tis | 1.00% | 0.34% | 0.34% | 2025-03-31 |
| WOODLINE PARTNERS LP | 993.07 tis | 0.97% | 0.04% | 0.11% | 2024-12-31 |
| MARSHALL WACE, LLP | 945.83 tis | 0.92% | 0.02% | 0.02% | 2024-12-31 |
| UBS GROUP AG | 826.06 tis | 0.84% | 0.00% | 0.00% | 2020-03-31 |
| NORTHERN TRUST CORP | 825.58 tis | 0.83% | 0.00% | 0.00% | 2020-03-31 |
| DEEP TRACK CAPITAL, LP | 820.77 tis | 0.83% | 0.32% | 0.32% | 2026-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 808.44 tis | 0.82% | 0.00% | 0.00% | 2020-03-31 |
| BNP PARIBAS ARBITRAGE, SNC | 700.65 tis | 0.71% | 0.00% | 0.01% | 2024-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 684.87 tis | 0.69% | 0.00% | 0.00% | 2026-03-31 |
| MORGAN STANLEY | 648.26 tis | 0.66% | 0.00% | 0.00% | 2020-03-31 |
| LOGOS GLOBAL MANAGEMENT LP | 500.00 tis | 0.61% | 1.32% | 1.32% | 2024-09-30 |
| ECOR1 CAPITAL, LLC | 526.69 tis | 0.60% | 0.61% | 0.61% | 2025-03-31 |
| RTW INVESTMENTS, LP | 570.39 tis | 0.58% | -0.02% | 0.14% | 2025-12-31 |
| JPMORGAN CHASE & CO | 551.36 tis | 0.56% | 0.00% | 0.00% | 2020-03-31 |
| BANK OF AMERICA CORP /DE/ | 538.29 tis | 0.54% | 0.00% | 0.00% | 2020-03-31 |
| CONTRARIUS GROUP HOLDINGS LTD | 533.44 tis | 0.54% | 0.72% | 0.72% | 2025-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 513.58 tis | 0.52% | 0.01% | 0.02% | 2025-12-31 |
| CAPTION MANAGEMENT, LLC | 532.50 tis | 0.52% | 0.08% | 0.10% | 2024-03-31 |
| YIHENG CAPITAL MANAGEMENT, L.P. | 426.10 tis | 0.52% | -0.55% | 0.41% | 2022-03-31 |
| TWO SIGMA ADVISERS, LP | 527.80 tis | 0.51% | 0.01% | 0.03% | 2024-03-31 |
| NORGES BANK | 410.80 tis | 0.50% | 0.00% | 0.00% | 2024-06-30 |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 488.42 tis | 0.49% | -0.14% | 0.88% | 2024-06-30 |
| 476.34 tis | 0.48% | -0.67% | 3.22% | 2025-12-31 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 492.43 tis | 0.48% | -0.05% | 0.05% | 2020-12-31 |
| ROYAL BANK OF CANADA | 416.26 tis | 0.41% | 0.00% | 0.00% | 2020-03-31 |
| AVIDITY PARTNERS MANAGEMENT LP | 409.40 tis | 0.40% | -1.25% | 1.39% | 2025-03-31 |
| BAILLIE GIFFORD & CO | 385.89 tis | 0.39% | 0.00% | 0.01% | 2020-12-31 |
| CORMORANT ASSET MANAGEMENT, LP | 300.00 tis | 0.39% | 0.43% | 0.43% | 2024-03-31 |
| BANK OF NEW YORK MELLON CORP | 344.49 tis | 0.35% | 0.00% | 0.00% | 2020-03-31 |
| EVENTIDE ASSET MANAGEMENT, LLC | 261.36 tis | 0.33% | 0.00% | 0.12% | 2022-09-30 |
| ALPHABET INC. | 321.60 tis | 0.33% | -0.15% | 0.19% | 2020-03-31 |
| BARCLAYS PLC | 326.18 tis | 0.32% | 0.00% | 0.00% | 2022-03-31 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 252.22 tis | 0.31% | 0.04% | 0.24% | 2022-06-30 |
| JANE STREET GROUP, LLC | 310.01 tis | 0.30% | 0.00% | 0.00% | 2020-12-31 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 300.00 tis | 0.30% | -0.42% | 0.34% | 2025-06-30 |
| PICTET ASSET MANAGEMENT HOLDING SA | 297.50 tis | 0.30% | 0.00% | 0.01% | 2023-09-30 |
| MILLENNIUM MANAGEMENT LLC | 301.65 tis | 0.29% | 0.00% | 0.00% | 2020-03-31 |
| SCHONFELD STRATEGIC ADVISORS LLC | 296.09 tis | 0.29% | 0.01% | 0.04% | 2021-06-30 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 223.93 tis | 0.29% | 0.01% | 0.01% | 2022-06-30 |
| AMERIPRISE FINANCIAL INC | 230.17 tis | 0.28% | 0.00% | 0.00% | 2021-12-31 |
| TWINBEECH CAPITAL LP | 238.91 tis | 0.27% | 0.03% | 0.08% | 2024-03-31 |
| CANDRIAM S.C.A. | 212.67 tis | 0.27% | 0.02% | 0.04% | 2021-06-30 |
| PEREGRINE INVESTMENT MANAGEMENT INC | 260.05 tis | 0.26% | 0.44% | 4.87% | 2024-12-31 |
| ALLIANCEBERNSTEIN L.P. | 212.80 tis | 0.26% | 0.00% | 0.00% | 2020-03-31 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 208.26 tis | 0.25% | 0.05% | 0.06% | 2024-09-30 |
| JEFFERIES FINANCIAL GROUP INC. | 195.00 tis | 0.25% | 0.02% | 0.06% | 2023-06-30 |
| CITIGROUP INC | 220.20 tis | 0.25% | 0.00% | 0.00% | 2020-03-31 |
| TANG CAPITAL MANAGEMENT LLC | 255.00 tis | 0.25% | 0.06% | 0.24% | 2023-12-31 |
| TD ASSET MANAGEMENT INC | 211.78 tis | 0.24% | 0.00% | 0.00% | 2024-03-31 |
| NUVEEN, LLC | 232.60 tis | 0.24% | 0.00% | 0.00% | 2025-03-31 |
| CITADEL ADVISORS LLC | 232.40 tis | 0.24% | 0.00% | 0.00% | 2020-12-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 193.36 tis | 0.23% | 0.01% | 0.01% | 2024-12-31 |
| MAN GROUP PLC | 231.99 tis | 0.23% | 0.01% | 0.01% | 2025-09-30 |
| RAFFERTY ASSET MANAGEMENT, LLC | 187.09 tis | 0.23% | 0.00% | 0.02% | 2020-12-31 |
| INVESCO LTD. | 219.96 tis | 0.22% | 0.00% | 0.00% | 2020-12-31 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 226.74 tis | 0.22% | 0.24% | 0.24% | 2025-06-30 |
| HRT FINANCIAL LP | 219.43 tis | 0.22% | 0.00% | 0.01% | 2025-09-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 181.64 tis | 0.22% | 0.00% | 0.00% | 2020-03-31 |
| RUSSELL INVESTMENTS GROUP, LTD. | 176.18 tis | 0.21% | 0.00% | 0.01% | 2020-12-31 |
| GREAT POINT PARTNERS LLC | 175.56 tis | 0.20% | 1.82% | 1.82% | 2025-03-31 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 170.61 tis | 0.19% | 0.00% | 0.00% | 2020-09-30 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 167.01 tis | 0.19% | 0.00% | 0.01% | 2024-06-30 |
| SQUAREPOINT OPS LLC | 155.28 tis | 0.19% | 0.00% | 0.00% | 2020-06-30 |
| BANK OF MONTREAL /CAN/ | 151.07 tis | 0.18% | 0.00% | 0.00% | 2024-06-30 |
| SWISS NATIONAL BANK | 180.60 tis | 0.18% | 0.00% | 0.00% | 2020-06-30 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 178.39 tis | 0.18% | 0.00% | 0.00% | 2020-12-31 |
| VESTMARK ADVISORY SOLUTIONS, INC. | 176.87 tis | 0.18% | -0.03% | 0.05% | 2023-12-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 175.00 tis | 0.17% | 0.01% | 0.01% | 2025-09-30 |
| AMERICAN CENTURY COMPANIES INC | 135.38 tis | 0.16% | 0.00% | 0.00% | 2023-09-30 |
| WELLS FARGO & COMPANY/MN | 128.00 tis | 0.16% | 0.00% | 0.00% | 2020-03-31 |
| WALLEYE CAPITAL LLC | 127.59 tis | 0.15% | 0.00% | 0.01% | 2024-03-31 |
| RHUMBLINE ADVISERS | 127.11 tis | 0.15% | 0.00% | 0.00% | 2020-03-31 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 126.71 tis | 0.15% | 0.07% | 0.21% | 2024-03-31 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 115.00 tis | 0.14% | 0.01% | 0.01% | 2024-06-30 |
| CREDIT SUISSE AG/ | 100.54 tis | 0.13% | 0.00% | 0.00% | 2020-09-30 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 84.06 tis | 0.11% | 0.00% | 0.01% | 2021-03-31 |
| LIONTRUST INVESTMENT PARTNERS LLP | 80.00 tis | 0.10% | 0.03% | 0.03% | 2024-06-30 |
| LEGAL & GENERAL GROUP PLC | 78.37 tis | 0.10% | 0.00% | 0.00% | 2020-03-31 |
| CAPITAL FUND MANAGEMENT S.A. | 77.70 tis | 0.10% | 0.00% | 0.01% | 2022-03-31 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 68.30 tis | 0.08% | 0.00% | 0.00% | 2020-03-31 |
| CLARIUS GROUP, LLC | 60.62 tis | 0.07% | -0.04% | 0.10% | 2021-06-30 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 59.10 tis | 0.07% | 0.00% | 0.00% | 2024-06-30 |
| KRILOGY FINANCIAL LLC | 51.34 tis | 0.06% | 0.00% | 0.09% | 2023-12-31 |
| DEKABANK DEUTSCHE GIROZENTRALE | 50.00 tis | 0.06% | 0.00% | 0.00% | 2020-12-31 |
| D.A. DAVIDSON & CO. | 49.63 tis | 0.06% | 0.00% | 0.01% | 2021-09-30 |
| TUDOR INVESTMENT CORP ET AL | 49.02 tis | 0.06% | 0.00% | 0.01% | 2024-03-31 |
| STATE OF WISCONSIN INVESTMENT BOARD | 46.74 tis | 0.06% | 0.00% | 0.00% | 2020-03-31 |
| VOYA INVESTMENT MANAGEMENT LLC | 44.17 tis | 0.05% | 0.00% | 0.00% | 2020-09-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Ciaramella Giuseppe | officer: President | S-Sale | 11810 | 24.58 | 6.4 2026 | 218406 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 5956 | 24.58 | 6.4 2026 | 109711 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | S-Sale | 3242 | 24.58 | 6.4 2026 | 51171 |
| Simon Amy | officer: Chief Medical Officer | S-Sale | 6700 | 24.58 | 6.4 2026 | 102735 |
| Evans John M. | director, officer: CEO | S-Sale | 30078 | 24.58 | 6.4 2026 | 1047205 |
| Ciaramella Giuseppe | officer: President | A-Award | 40000 | 0.00 | 2.4 2026 | 230216 |
| Emany Sravan Kumar | officer: Chief Financial Officer | A-Award | 31750 | 0.00 | 2.4 2026 | 105456 |
| Simon Amy | officer: Chief Medical Officer | A-Award | 31750 | 0.00 | 2.4 2026 | 109114 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | A-Award | 20000 | 0.00 | 2.4 2026 | 54813 |
| Bellon Christine | officer: Chief Legal Officer | A-Award | 20000 | 0.00 | 2.4 2026 | 115667 |
| Evans John M. | director, officer: CEO | M-Exempt | 25000 | 0.67 | 1.4 2026 | 18672 |
| Evans John M. | director, officer: CEO | M-Exempt | 25000 | 0.67 | 1.4 2026 | 43672 |
| Evans John M. | director, officer: CEO | S-Sale | 25000 | 22.76 | 1.4 2026 | 986667 |
| Evans John M. | director, officer: CEO | S-Sale | 25000 | 22.37 | 1.4 2026 | 986667 |
| Evans John M. | director, officer: CEO | M-Exempt | 25000 | 0.67 | 1.4 2026 | 1011667 |
| Evans John M. | director, officer: CEO | A-Award | 90000 | 0.00 | 1.4 2026 | 1076667 |
| Ciaramella Giuseppe | officer: President | S-Sale | 35000 | 32.00 | 26.2 2026 | 190216 |
| Ciaramella Giuseppe | officer: President | M-Exempt | 35000 | 17.00 | 26.2 2026 | 225216 |
| Ciaramella Giuseppe | officer: President | M-Exempt | 35000 | 17.00 | 26.2 2026 | 397313 |
| Simon Amy | officer: Chief Medical Officer | A-Award | 88500 | 27.62 | 2.2 2026 | 88500 |
| Evans John M. | director, officer: CEO | M-Exempt | 19336 | 0.67 | 2.2 2026 | 0 |
| Evans John M. | director, officer: CEO | M-Exempt | 25000 | 0.67 | 2.2 2026 | 68672 |
| Evans John M. | director, officer: CEO | M-Exempt | 5664 | 0.67 | 2.2 2026 | 93672 |
| Evans John M. | director, officer: CEO | A-Award | 180000 | 27.62 | 2.2 2026 | 180000 |
| Evans John M. | director, officer: CEO | S-Sale | 2906 | 29.00 | 2.2 2026 | 986667 |
| Evans John M. | director, officer: CEO | S-Sale | 8667 | 29.74 | 2.2 2026 | 986667 |
| Evans John M. | director, officer: CEO | S-Sale | 22094 | 28.27 | 2.2 2026 | 989573 |
| Evans John M. | director, officer: CEO | S-Sale | 16333 | 29.19 | 2.2 2026 | 995334 |
| Evans John M. | director, officer: CEO | M-Exempt | 19336 | 0.67 | 2.2 2026 | 1006003 |
| Evans John M. | director, officer: CEO | M-Exempt | 25000 | 0.67 | 2.2 2026 | 1011667 |
| Bellon Christine | officer: Chief Legal Officer | A-Award | 40000 | 27.62 | 2.2 2026 | 40000 |
| Emany Sravan Kumar | officer: Chief Financial Officer | A-Award | 63500 | 27.62 | 2.2 2026 | 63500 |
| Ciaramella Giuseppe | officer: President | A-Award | 80000 | 27.62 | 2.2 2026 | 80000 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | A-Award | 40000 | 27.62 | 2.2 2026 | 40000 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 1371 | 34.00 | 26.1 2026 | 95667 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | S-Sale | 6198 | 35.00 | 26.1 2026 | 34813 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | S-Sale | 3034 | 30.12 | 21.1 2026 | 41011 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 559 | 35.40 | 20.1 2026 | 97038 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 15959 | 34.72 | 20.1 2026 | 97597 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 2111 | 33.62 | 20.1 2026 | 113556 |
| Simon Amy | officer: Chief Medical Officer | A-Award | 12500 | 0.00 | 5.1 2026 | 77364 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 1254 | 27.10 | 5.1 2026 | 115667 |
| Emany Sravan Kumar | officer: Chief Financial Officer | S-Sale | 6294 | 27.10 | 5.1 2026 | 73706 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 459 | 26.68 | 29.10 2025 | 14 |
| FMR LLC | 10 percent owner, other: See Remark 1 | G-Gift | 1232434 | 0.00 | 8.10 2025 | 841231 |
| Evans John M. | director, officer: CEO | M-Exempt | 25000 | 0.67 | 3.10 2025 | 19336 |
| Evans John M. | director, officer: CEO | M-Exempt | 25000 | 0.67 | 3.10 2025 | 44336 |
| Evans John M. | director, officer: CEO | S-Sale | 25000 | 24.51 | 3.10 2025 | 986667 |
| Evans John M. | director, officer: CEO | S-Sale | 25000 | 24.63 | 3.10 2025 | 986667 |
| Evans John M. | director, officer: CEO | M-Exempt | 25000 | 0.67 | 3.10 2025 | 1011667 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 373 | 24.53 | 3.10 2025 | 116921 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | S-Sale | 467 | 24.53 | 3.10 2025 | 44045 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 48374 | 20.50 | 1.8 2025 | 2073665 |
| Simon Amy | officer: Chief Medical Officer | S-Sale | 876 | 20.12 | 3.7 2025 | 64864 |
| Simon Amy | officer: Chief Medical Officer | S-Sale | 374 | 16.94 | 3.7 2025 | 65740 |
| Guindo Chirfi | director | A-Award | 33662 | 17.15 | 6.6 2025 | 33662 |
| COOPER GRAHAM K | director | A-Award | 33662 | 17.15 | 6.6 2025 | 33662 |
| MARAGANORE JOHN | director | A-Award | 33662 | 17.15 | 6.6 2025 | 33662 |
| Ho Carole | director | A-Award | 33662 | 17.15 | 6.6 2025 | 33662 |
| Shaw Christi | director | A-Award | 33662 | 17.15 | 6.6 2025 | 33662 |
| Fishman Mark | director | A-Award | 33662 | 17.15 | 6.6 2025 | 33662 |
| Walsh Kathleen E | director | A-Award | 33662 | 17.15 | 6.6 2025 | 33662 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 0 | 0.00 | 10.4 2025 | 473 | |
| FMR LLC | 10 percent owner, other: See Remark 1 | 0 | 0.00 | 10.4 2025 | 1139443 | |
| FMR LLC | 10 percent owner, other: See Remark 1 | 0 | 0.00 | 10.4 2025 | 2122039 | |
| Simon Amy | officer: Chief Medical Officer | S-Sale | 20997 | 17.73 | 3.4 2025 | 65742 |
| Simon Amy | officer: Chief Medical Officer | S-Sale | 9566 | 18.35 | 3.4 2025 | 86739 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | S-Sale | 3015 | 18.35 | 3.4 2025 | 44512 |
| Ciaramella Giuseppe | officer: President | S-Sale | 7434 | 18.35 | 3.4 2025 | 190216 |
| Evans John M. | director, officer: CEO | S-Sale | 30663 | 18.35 | 3.4 2025 | 986249 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 5674 | 18.35 | 3.4 2025 | 117294 |
| Evans John M. | director, officer: CEO | M-Exempt | 30000 | 0.67 | 2.4 2025 | 69336 |
| Evans John M. | director, officer: CEO | M-Exempt | 30000 | 0.67 | 2.4 2025 | 968659 |
| Evans John M. | director, officer: CEO | A-Award | 77500 | 0.00 | 2.4 2025 | 1016159 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | A-Award | 10000 | 0.00 | 2.4 2025 | 47527 |
| Ciaramella Giuseppe | officer: President | A-Award | 35000 | 0.00 | 2.4 2025 | 197650 |
| Simon Amy | officer: Chief Medical Officer | A-Award | 27500 | 0.00 | 2.4 2025 | 96305 |
| Bellon Christine | officer: Chief Legal Officer | A-Award | 20000 | 0.00 | 2.4 2025 | 122968 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | S-Sale | 6287 | 35.00 | 20.2 2025 | 37527 |
| Bellon Christine | officer: Chief Legal Officer | M-Exempt | 9492 | 7.22 | 19.2 2025 | 0 |
| Bellon Christine | officer: Chief Legal Officer | M-Exempt | 508 | 7.22 | 19.2 2025 | 10410 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 10000 | 34.00 | 19.2 2025 | 102968 |
| Bellon Christine | officer: Chief Legal Officer | M-Exempt | 9492 | 7.22 | 19.2 2025 | 112460 |
| Bellon Christine | officer: Chief Legal Officer | M-Exempt | 508 | 7.22 | 19.2 2025 | 112968 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | A-Award | 20000 | 25.92 | 3.2 2025 | 20000 |
| Evans John M. | director, officer: CEO | A-Award | 155000 | 25.92 | 3.2 2025 | 155000 |
| Evans John M. | director, officer: CEO | S-Sale | 200 | 27.28 | 3.2 2025 | 908659 |
| Evans John M. | director, officer: CEO | S-Sale | 29800 | 26.75 | 3.2 2025 | 908859 |
| Simon Amy | officer: Chief Medical Officer | A-Award | 55000 | 25.92 | 3.2 2025 | 55000 |
| Ciaramella Giuseppe | officer: President | A-Award | 70000 | 25.92 | 3.2 2025 | 70000 |
| Bellon Christine | officer: Chief Legal Officer | A-Award | 40000 | 25.92 | 3.2 2025 | 40000 |
| Cavanagh Bethany J | officer: SVP, Finance and Treasurer | S-Sale | 1117 | 24.68 | 6.1 2025 | 43814 |
| Bellon Christine | officer: Chief Legal Officer | S-Sale | 1241 | 24.68 | 6.1 2025 | 102968 |
| Emany Sravan Kumar | officer: Chief Financial Officer | A-Award | 80000 | 0.00 | 2.1 2025 | 80000 |
| Emany Sravan Kumar | officer: Chief Financial Officer | A-Award | 160000 | 24.80 | 2.1 2025 | 160000 |
| Emany Sravan Kumar | 0 | 0.00 | 19.12 2024 | 0 | ||
| Ciaramella Giuseppe | officer: President | M-Exempt | 53500 | 0.67 | 19.12 2024 | 6505 |
| Ciaramella Giuseppe | officer: President | M-Exempt | 53500 | 0.67 | 19.12 2024 | 162650 |
| Guindo Chirfi | 0 | 0.00 | 4.12 2024 | 0 | ||
| Guindo Chirfi | director | A-Award | 39086 | 28.30 | 4.12 2024 | 39086 |
